CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development	$ 14,482	$ 17,384
Selling, general and administrative	19,799	21,551
Total operating expenses	34,281	38,935
Loss from operations	(7,979)	(14,146)
Non-operating expense, net:
Foreign exchange gain (loss)	145	(193)
Interest expense	(2,234)	(1,612)
Other income, net	452	387
Total non-operating expense, net	(1,637)	(1,418)
Loss before income taxes	(9,616)	(15,564)
Provision for income taxes	74	77
Net loss	(9,690)	(15,641)
Net loss attributable to noncontrolling interest	(2)	(22)
Net loss attributable to Cerus Corporation	$ (9,688)	$ (15,619)
Net loss per share attributable to Cerus Corporation
Basic	$ (0.05)	$ (0.09)
Diluted	$ (0.05)	$ (0.09)
Weighted average shares outstanding:
Basic	182,090	178,273
Diluted	182,090	178,273
Product
Revenue	$ 38,365	$ 30,974
Cost of revenue	17,093	13,687
Gross profit	21,272	17,287
Government Contract
Revenue	$ 5,030	$ 7,502